Últimas noticias sobre Vaxcyte (NASDAQ:PCVX) Bolsa

VAXCYTE INC

Vaxcyte

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

News

General

Norfolk Southern Corp Says Union Pacific Will Pay Co A Termination Fee Of $2.5B In Cash In Certain Circumstances If Deal Is Terminated; Co, Union Pacific To Pay The Other $2.5B If Deal Terminated Due To Change In Board Recommendation Or Alternative Proposals

Wells Fargo analyst Edward Kelly maintains Sysco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYY#NYSE">SYY</a>) with a Overweight and raises the price target from $80 to $88.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Sysco, Raises Price Target to $88

WIIM

LOGI

LOGI stock has given up its prior gain. Logitech International shares were trading higher after the company reported better-than-expected Q1 financial results.

Shares of casino company Caesars Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) are trading lower after the company reported second quarter financial results Tuesday<a href="https://www.benzinga.com/earnings"> after market close.</a>
CZR stock is currently down. <a href="https://www.benzinga.com/quote/CZR" target="_blank" rel="noreferrer noopener">See real-time price here.</a>
Here are the key highlights.
Q2 Results: Caesars reported second-quarter revenue of $2.91 billion, up 2.9% year-over-year. The revenue beat a Street consensus estimate of $2.86 billion, according to data <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0729">from Benzinga Pro. </a>
The company reported a net loss of 39 cents per share, missing a Street consensus estimate of 12 cents per share.
Among the items contributing the net loss was net income down 20.9% for the company's Las Vegas segment. The Las Vegas segment saw a revenue decline in the quarter, as shown below.
Here were the revenue totals for the second quarter by segment:
<ul class="wp-block-list">
<li>Las Vegas: $1.05 billion, -3.7% year-over-year</li>
<li>Regional: $1.44 billion, +3.6% year-over-year</li>
<li>Caesars Digital: $343 million, +24.3% year-over-year</li>
<li>Managed &amp; Branded: $74 million, +5.7% year-over-year</li>
</ul>
"Our Caesars Digital segment posted one of its strongest quarters ever, as momentum continues to build toward the financial goals that we originally laid out in 2021," Caesars Entertainment CEO Tom Reeg said.
The company's strength for the digital segment was offset by Las Vegas.
"In Las Vegas, we posted solid gaming results in the face of softer market demand in our hospitality verticals."
CZR Price Action: Caesars stock is down 3.20% to $27.56 in after-hours trading Tuesday versus a 52-week trading range of $21.40 to $45.89. The stock was also down over 3% during the intraday session.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/quote/CZR/analyst-ratings">Analyst Ratings For Caesars Entertainment </a></li>
</ul>
Photo: Shutterstock

Earnings

Gaming

After-Hours Center

Movers

Caesars Entertainment Stock Misses Jackpot With Las Vegas Revenue Decline

William Blair analyst Brandon Vazquez downgrades Neogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOG#NASDAQ">NEOG</a>) from Outperform to Market Perform.

Downgrades

NEOG

William Blair Downgrades Neogen to Market Perform

Luxfer Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXFR#NYSE">LXFR</a>) raises FY2025 Adj EPS guidance from $0.95-$1.05 to $0.97-$1.05 vs $1.00 analyst estimate..

Guidance

LXFR

Luxfer Holdings Raises FY2025 Adj EPS Guidance from $0.95-$1.05 to $0.97-$1.05 vs $1.00 Est

William Blair downgrades NeoGenomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) from Outperform to Market Perform.

William Blair Downgrades NeoGenomics to Market Perform

Offerings

BTCS

BTCS Files For Mixed Shelf Of Up To $2B

Anteris Technologies Global Enters Amended Agreement With Switchback Medical; Grants Switchback Limited, Exclusive IP License; Agreement Expires March 31, 2028 With Auto Renewals

Management

ZYXI

Zynex Dan Moorhead Resigns As CFO  Effective August 29, 2025

Carnival (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) has outperformed the market over the past 5 years by 3.76% on an annualized basis producing an average annual return of 17.84%. Currently, Carnival has a market capitalization of $40.27 billion. 
Buying $1000 In CCL: If an investor had bought $1000 of CCL stock 5 years ago, it would be worth $2,139.77 today based on a price of $29.70 for CCL at the time of writing.
<h3>Carnival's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753825519_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Avis Budget Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) shares declined on Tuesday after the company reported second-quarter financial results. Here&#8217;s what you need to know <a href="https://www.benzinga.com/pressreleases/25/07/g46704371/avis-budget-group-reports-second-quarter-results">from the report</a>.
CAR stock is tumbling today. <a href="https://www.benzinga.com/quote/CAR" target="_blank" rel="noreferrer noopener">Track it now here.</a>
What To Know: Avis reported second-quarter revenue of $3 billion, missing analyst estimates of $3.02 billion. The company reported second-quarter adjusted earnings of 10 cents per share, missing estimates of $1.75 per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. 
Avis highlighted net income of $5 million, alongside adjusted EBITDA of $277 million. The company reported a 1% decrease in revenue per day, excluding exchange rate effects, while rental days remained flat compared to the same period last year. 
Adjusted EBITDA in the Americas rose to $220 million from $186 million, driven by lower fleet costs and increased vehicle utilization. The international segment saw a significant improvement in adjusted EBITDA, reaching $82 million compared to $48 million last year, due to stronger pricing and better vehicle utilization.
Avis Budget Group&#8217;s liquidity position was nearly $950 million at the end of the quarter, with an additional $1.7 billion in fleet funding capacity. 
&#8220;At Avis Budget Group, we&#8217;re building to scale where we hold structural advantages. With Avis First, we&#8217;ve created the category of first-class car rental; designed through product innovation and delivered with operational excellence,&#8221; said Brian Choi, CEO of Avis Budget Group.
&#8220;With our Waymo partnership, we&#8217;re stepping into the autonomous future as a critical enabler of next-generation fleet management.&#8221;
Tuesday morning, Avis announced a <a href="https://www.benzinga.com/pressreleases/25/07/g46686016/avis-budget-group-announces-multi-year-strategic-partnership-with-waymo">multi-year strategic partnership</a> with Waymo. The company will serve as Waymo&#8217;s fleet operations partner in Dallas. Initial testing is underway and a public launch is planned for 2026.
CAR Price Action: <a href="http://benzinga.com/quote/AVIS">Avis Budget Group shares</a> were down 4.23% at $195.25 during after-hours trading on Tuesday, <a href="https://pro.benzinga.com/">according to Benzinga Pro</a>.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/insights/earnings/25/07/46667608/whats-next-avis-budget-grs-earnings-preview">What&#8217;s Next: Avis Budget Gr&#8217;s Earnings Preview</a></li>
</ul>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/insights/options/25/07/46633974/what-the-options-market-tells-us-about-avis-budget-gr">What the Options Market Tells Us About Avis Budget Gr</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/Ian+Dewar+Photography">Ian Dewar Photography</a>/Shutterstock.com

Avis Budget Group Stock Skids After Q2 Earnings Miss

SBUX

During Conf Call, Starbucks Exec On China Business Partnership Says Got Significant Interest From More Than 20 Interested Parties, And We're Evaluating Options

Barclays analyst David Strauss maintains Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) with a Overweight and raises the price target from $210 to $255.

Barclays Maintains Overweight on Boeing, Raises Price Target to $255

BXP Sees Q3 FFO $1.69-$1.71 vs $1.76 Est

BXP Raises FY2025 FFO Guidance from $6.80-$6.92 to $6.84-$6.92 vs $6.88 Est

Earnings Beats

Boston Props Q2 FFO $1.71 Beats $1.68 Estimate, Sales $868.457M Beat $857.849M Estimate

Algoma Steel Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTL#NASDAQ">ASTL</a>) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.65) by 13.38 percent. This is a 2.36 percent decrease over losses of $(0.72) per share from the same period last year. The company reported quarterly sales of $426.021 million which missed the analyst consensus estimate of $608.000 million by 29.93 percent. This is a 3.18 percent decrease over sales of $440.030 million the same period last year.

Earnings Misses

ASTL

Algoma Steel Gr Q2 EPS $(0.74) Misses $(0.65) Estimate, Sales $426.021M Miss $608.000M Estimate

Jefferies analyst Roger Song maintains Kiniksa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNSA#NASDAQ">KNSA</a>) with a Buy and raises the price target from $45 to $54.

KNSA

Jefferies Maintains Buy on Kiniksa Pharmaceuticals, Raises Price Target to $54

CBL Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBL#NYSE">CBL</a>) today announced that it has acquired four dominant enclosed regional malls for $178.9 million from Washington Prime Group. The malls include Ashland Town Center in Ashland, KY, Mesa Mall in Grand Junction, CO, Paddock Mall in Ocala, FL, and Southgate Mall in Missoula, MT. This acquisition reinforces CBL's position as the preeminent owner and manager of successful enclosed malls in dynamic and growing middle markets.
"We are thrilled to add these four dominant enclosed malls to the CBL portfolio," said Stephen D. Lebovitz, CEO of CBL Properties. "Each property fits perfectly within our existing portfolio. They enhance CBL's operating metrics, augmenting sales and occupancy and offer both near- and long-term growth opportunities."
The transaction represents significant progress in the execution of CBL's portfolio optimization strategy – to redeploy proceeds from non-core asset sales into stable and growing assets that generate immediate accretion to CBL's portfolio cash yield. In 2024 and year-to-date in 2025, CBL has completed sales of more than $241 million in non-core malls, open-air centers and outparcels. Most recently, CBL closed the $83.1 million sale of The Promenade, a premier power center in D'Iberville, MS, at an attractive single-digit cap rate. Additional open-air center dispositions are planned for the near-term, which will generate attractively priced capital from an undervalued segment of CBL's portfolio.
Lebovitz added, "This transaction exemplifies our ability to strategically leverage the attractive valuations of our high-quality open-air and outparcel portfolio to fund investments in market-dominant enclosed malls. Each of these newly acquired assets enjoys strong market positioning and both near and long-term growth potential. The acquisition is immediately accretive to CBL's cash flow per share and FFO, and moderately deleveraging to our balance sheet. Additionally, the scalability of our existing platform allows for seamless integration of the properties into our existing portfolio, further enhancing the financial benefits of the transaction. Growing cash flow through our portfolio optimization strategy remains a top priority as we continue to focus on delivering strong returns to our shareholders."
Concurrently with the transaction close, CBL completed a modification and extension of its existing $333.0 million non-recourse outparcel and open-air center loan with Beal Bank USA, which was scheduled to initially mature in June 2027, with one, two-year extension option. The loan was modified to include the acquisition properties, increasing the principal balance by $110.0 million to approximately $443.0 million and providing for a seven-year term, comprised of an initial maturity in October 2030, with one, two-year extension option for a final maturity in October 2032. For the initial five-year term, the new interest-only loan will bear a fixed interest rate of 7.70% on a principal balance of approximately $368.0 million and a floating interest rate of SOFR plus 410 basis points on the remaining balance of approximately $75.0 million. The interest rate on the full principal balance will convert to the floating rate after the initial term.
"We are pleased to further our relationship with Beal Bank through this transaction," said Ben Jaenicke, EVP - CFO of CBL Properties. "This financing strengthens our balance sheet by extending our maturities, reducing interest rate risk, and locking in the attractive returns and cash flow generation from the four-mall acquisition."
Matt Hart of CSG Investments, Inc. noted, "On behalf of our broader team at Beal Bank USA, we are delighted to have this opportunity to expand and extend our support for CBL and their growing portfolio of market-dominant retail properties."
Additional information on the transaction is available in the Investor Relations - Presentations section of CBL's website: <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvest.cblproperties.com%2Finvestor-relations%2Freports-presentations-webcasts%2Fdefault.aspx&amp;esheet=54299119&amp;newsitemid=20250729935161&amp;lan=en-US&amp;anchor=CBL+Properties+-+Investor+Relations+-+Reports%2C+Presentations+%26amp%3B+Webcasts&amp;index=1&amp;md5=44066a5a6187267a8c7ff282245f0aa6">CBL Properties - Investor Relations - Reports, Presentations &amp; Webcasts</a>

CBL & Associates Properties Acquires Four Dominant Enclosed Regional Malls For $178.9M From Washington Prime Group

Press Releases

Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm

Legal

Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference

Health Care

Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study

Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update

Comments

Vaxcyte

Noticias

Últimas noticias sobre Vaxcyte (NASDAQ:PCVX) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL